ENXTPA:DGM

Stock Analysis Report

Diagnostic Medical Systems

Executive Summary

Diagnostic Medical Systems S.A. operates in the medical imaging industry in France.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Risks

  • Diagnostic Medical Systems is not covered by any analysts.

Share Price & News

How has Diagnostic Medical Systems's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.9%

ENXTPA:DGM

-1.4%

FR Medical Equipment

-0.8%

FR Market


1 Year Return

-6.3%

ENXTPA:DGM

-7.6%

FR Medical Equipment

-1.5%

FR Market

DGM outperformed the Medical Equipment industry which returned -7.6% over the past year.

DGM underperformed the Market in France which returned -1.5% over the past year.


Share holder returns

DGMIndustryMarket
7 Day-0.9%-1.4%-0.8%
30 Day2.8%0.8%-4.7%
90 Day-2.2%-0.9%-2.8%
1 Year-6.3%-6.3%-6.6%-7.6%1.8%-1.5%
3 Year-48.1%-48.1%38.7%35.7%39.1%25.5%
5 Year-54.8%-57.3%85.6%79.6%56.4%33.2%

Price Volatility Vs. Market

How volatile is Diagnostic Medical Systems's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Diagnostic Medical Systems undervalued based on future cash flows and its price relative to the stock market?

0.99x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Diagnostic Medical Systems to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Diagnostic Medical Systems to establish if it is available at substantial discount.


Price Based on Earnings

Diagnostic Medical Systems is loss making, we can't compare its value to the Europe Medical Equipment industry average.

Diagnostic Medical Systems is loss making, we can't compare the value of its earnings to the France market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Diagnostic Medical Systems, we can't assess if its growth is good value.


Price Based on Value of Assets

Diagnostic Medical Systems is good value based on assets compared to the FR Medical Equipment industry average.


Next Steps

Future Growth

How is Diagnostic Medical Systems expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

12.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Diagnostic Medical Systems has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Diagnostic Medical Systems performed over the past 5 years?

-36.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Diagnostic Medical Systems does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Diagnostic Medical Systems's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Diagnostic Medical Systems's 1-year growth to the Europe Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Diagnostic Medical Systems has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Diagnostic Medical Systems has efficiently used its assets last year compared to the Europe Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Diagnostic Medical Systems improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Diagnostic Medical Systems's financial position?


Financial Position Analysis

Diagnostic Medical Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Diagnostic Medical Systems's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Diagnostic Medical Systems's level of debt (37%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has increased over the past 5 years (23.6% vs 37% today).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 3.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Diagnostic Medical Systems has less than a year of cash runway based on current free cash flow.

Diagnostic Medical Systems has less than a year of cash runway if free cash flow continues to reduce at historical rates of -1.6% each year.


Next Steps

Dividend

What is Diagnostic Medical Systems's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Diagnostic Medical Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Diagnostic Medical Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Diagnostic Medical Systems has not reported any payouts.

Unable to verify if Diagnostic Medical Systems's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Diagnostic Medical Systems has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Diagnostic Medical Systems's salary, the management and board of directors tenure and is there insider trading?

€257k

CEO Compensation


CEO

Jean-Paul Ansel 0

0.0yrs

Tenure

€257,000

Compensation

Mr. Jean-Paul Ansel serves as the Chief Executive Officer of Diagnostic Medical Systems S.A. and has been its Chairman since 2010. Mr. Ansel served as the Chairman and Chief Executive Officer of Alpha MOS  ...


CEO Compensation Analysis

Jean-Paul's remuneration is lower than average for companies of similar size in France.

Jean-Paul's compensation has increased whilst company is loss making.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Samuel Sancerni

    Deputy Chief Executive Officer and Director

    • Tenure: 0.0yrs
    • Compensation: €141.29k
  • Jean-Paul Ansel

    Chairman of the Board & CEO

    • Tenure: 0.0yrs
    • Compensation: €257.00k
  • Nathalie Richard

    Human Resources Director

    • Tenure: 0.5yrs

Board Members

  • Samuel Sancerni

    Deputy Chief Executive Officer and Director

    • Tenure: 0.0yrs
    • Compensation: €141.29k
  • Jean-Paul Ansel

    Chairman of the Board & CEO

    • Tenure: 0.0yrs
    • Compensation: €257.00k
  • Simonyi See-Nuan

    Director

    • Tenure: 0.0yrs
    • Compensation: €11.50k
  • Jean Mifsud

    Director

    • Tenure: 0.0yrs

Company Information

Diagnostic Medical Systems S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Diagnostic Medical Systems S.A.
  • Ticker: DGM
  • Exchange: ENXTPA
  • Founded: 1993
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €17.894m
  • Shares outstanding: 16.12m
  • Website: https://www.dms.com

Number of Employees


Location

  • Diagnostic Medical Systems S.A.
  • 393 rue Charles Lindbergh
  • Mauguio
  • Languedoc-Roussillon
  • 34130
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DGMENXTPA (Euronext Paris)YesOrdinary SharesFREURMay 1998
DGMPBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURMay 1998

Biography

Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. It offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D recon ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/18 20:50
End of Day Share Price2019/08/16 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.